Steven R. Hagen, SVP Pharmaceutical Development & Mfg at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 1,250 shares at $19.74 ($25K) on 2014-08-28, disclosed to the SEC on 2014-09-02.
Open-market sale of $25k AMRI by SVP Pharmaceutical Development & Mfg. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AMRI | SELL | 2016-08-10 | $21K | — | Filing → |
| AMRI | SELL | 2016-05-16 | $30K | — | Filing → |
| AMRI | SELL | 2015-08-17 | $20K | — | Filing → |